MUC1 is highly expressed in various cancer cells especially in breast cancer cells, and there is evidence indicating that the application of antibodies to MUC1 in combination with dinuclear platinum (II) complex can improve breast cancer treatment response (32). Here, MUC1 is linked to breast cancer.